Northwest & Ethical Investments L.P.
Position in BSX — Boston Scientific Corp
CIK 2033536
TORONTO, A6
Position in BSX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$800,079
-$4,294,091 QoQ
Shares Held
18,746
-76.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#735
of 1,468 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $23,204,336 across 6 Medical Devices names. BSX ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
210,858 | $16,495,421 | |
| 2 | ABT |
Abbott Laboratories
|
42,896 | $3,892,383 | |
| 3 | STE |
STERIS plc
|
7,563 | $1,592,540 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
18,746 | $800,079 | |
| 5 | PROF |
Profound Medical Corp.
|
38,200 | $254,030 | |
| 6 | EW |
Edwards Lifesciences Corp
|
1,878 | $169,883 |
All Filings in BSX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $800,079 | 18,746 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,094,170 | 81,182 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,119,243 | 85,152 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,823,189 | 80,131 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,792,595 | 72,550 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,500,428 | 74,350 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,647,908 | 74,428 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,209,412 | 74,098 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,985,061 | 38,762 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $369,572 | 5,396 | Shares | Sole | 2025-07-09 | |
| No filing history on record for this holder in this stock. | ||||||